biotech · Post Traumatic Stress Disorder · Prosthetic Joint Infection · ADPT
Adaptive Biotechnologies
Adaptive Biotechnologies Corp
Adaptive Biotechnologies trial registry — 21 ClinicalTrials.gov studies with program phase, status, and indication context.
1165 Eastlake Ave E, Seattle, Washington 98109, US HQ
2009 Founded
659 Employees
Public company Type
ADPT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1165 Eastlake Ave E, Seattle, Washington 98109, US
- Founded
- 2009
- Employees
- 659
- Programs
- 19
- Drugs
- 23
- Patents
- 12
Adaptive Biotechnologies clinical trials
Registry index of 21 ClinicalTrials.gov studies linked to Adaptive Biotechnologies programs — each row shows trial ID, program name, phase, status, and indication.
Adaptive Biotechnologies trial registry — 21 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Adaptive Biotechnologies.
-
GCAR-7213 — Phase 3
Clinical update -
Venetoclax monotherapy — Phase 2
Clinical update -
Phage Therapy — Phase 2
Clinical update -
Mosunetuzumab — Phase 2
Clinical update -
Intervention B Vilazodone Hydrochloride (HCl) — Phase 2
Clinical update -
Intervention A Fluoxetine Hydrochloride (HCl) — Phase 2
Clinical update -
Ceftriaxone — Phase 3
Clinical update -
Bendamustine — Phase 2
Clinical update